High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
作者： R. Stupp , J.-C. Tonn , M. Brada , G. Pentheroudakis
关键词: Medicine 、 Secondary prevention 、 Clinical Practice 、 Adrenal cortex hormones 、 Neoplasm staging 、 University hospital 、 Surgery 、 Treatment outcome 、 General surgery 、 Diagnosis treatment 、 Glioblastoma
摘要: High-grade malignant glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up R. Stupp, J.-C. Tonn, M. Brada & G. Pentheroudakis On behalf of the Working Group* Centre Hospitalier Universitaire Vaudois (CHUV) University Lausanne, Department Oncology-Hematology Riveria-Chablais, Vevey, Switzerland; Neurosurgery, Universitatsklinikum Grosshadern, Ludwig-Maximilians-University Munich, Germany; Institute Cancer Research Royal Marsden NHS Foundation Trust, Sutton, UK; Medical Oncology, Ioannina Hospital, Ioannina, Greece
annalsofoncology.org
oxfordjournals.org
oup.com
core.ac.uk
paperity.org参考文章(36)
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
J R Wood, S B Green, W R Shapiro, The prognostic importance of tumor size in malignant gliomas: a computed tomographic scan study by the Brain Tumor Cooperative Group. Journal of Clinical Oncology. ,vol. 6, pp. 338- 343 ,(1988) , 10.1200/JCO.1988.6.2.338
Eric T. Wong, Kenneth R. Hess, Mary Jo Gleason, Kurt A. Jaeckle, Athanassios P. Kyritsis, Michael D. Prados, Victor A. Levin, W.K. Alfred Yung, Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials Journal of Clinical Oncology. ,vol. 17, pp. 2572- 2578 ,(1999) , 10.1200/JCO.1999.17.8.2572
D R Macdonald, T L Cascino, S C Schold, J G Cairncross, Response criteria for phase II studies of supratentorial malignant glioma. Journal of Clinical Oncology. ,vol. 8, pp. 1277- 1280 ,(1990) , 10.1200/JCO.1990.8.7.1277
M. Westphal, Z. Ram, V. Riddle, D. Hilt, E. Bortey, , Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochirurgica. ,vol. 148, pp. 269- 275 ,(2006) , 10.1007/S00701-005-0707-Z
Walter Rachinger, Claudia Goetz, Gabriele Pöpperl, Franz Josef Gildehaus, Friedrich Wilhelm Kreth, Markus Holtmannspötter, Jochen Herms, Walter Koch, Klaus Tatsch, Jörg-Christian Tonn, Positron emission tomography with O-(2-[18F]fluoroethyl)-l-tyrosine versus magnetic resonance imaging in the diagnosis of recurrent gliomas. Neurosurgery. ,vol. 57, pp. 505- 511 ,(2005) , 10.1227/01.NEU.0000171642.49553.B0
A. D. Norden, G. S. Young, K. Setayesh, A. Muzikansky, R. Klufas, G. L. Ross, A. S. Ciampa, L. G. Ebbeling, B. Levy, J. Drappatz, S. Kesari, P. Y. Wen, Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology. ,vol. 72, pp. 779- 787 ,(2008) , 10.1212/01.WNL.0000304121.57857.38
Michael Weller, Roger Stupp, Guido Reifenberger, Alba A. Brandes, Martin J. van den Bent, Wolfgang Wick, Monika E. Hegi, MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nature Reviews Neurology. ,vol. 6, pp. 39- 51 ,(2010) , 10.1038/NRNEUROL.2009.197
Patrick Y. Wen, Santosh Kesari, Malignant Gliomas in Adults The New England Journal of Medicine. ,vol. 359, pp. 492- 507 ,(2008) , 10.1056/NEJMRA0708126
Roger Stupp, Monika E. Hegi, Mark R. Gilbert, Arnab Chakravarti, Chemoradiotherapy in malignant glioma: standard of care and future directions. Journal of Clinical Oncology. ,vol. 25, pp. 4127- 4136 ,(2007) , 10.1200/JCO.2007.11.8554